Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,160 | -2,379 | -13,218 | -10,387 | -6,247 |
| Depreciation Amortization | 16 | 8 | 19 | 14 | 9 |
| Income taxes - deferred | N/A | N/A | -1,342 | N/A | N/A |
| Accounts receivable | N/A | N/A | N/A | -565 | -109 |
| Accounts payable and accrued liabilities | -350 | -484 | -706 | -754 | -441 |
| Other Working Capital | -1,207 | -1,889 | 7,111 | 4,566 | 3,228 |
| Other Operating Activity | 641 | 630 | 1,667 | 2,110 | 1,062 |
| Operating Cash Flow | $-6,060 | $-4,115 | $-6,469 | $-5,015 | $-2,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -37 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-37 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -3 | -13 | -10 | -6 |
| Common Stock Issued | 754 | N/A | 54 | 10,589 | 10,589 |
| Other Financing Activity | 10,109 | -40 | 10,630 | 41 | 41 |
| Financing Cash Flow | $10,857 | $-44 | $10,671 | $10,620 | $10,624 |
| Exchange Rate Effect | 2 | 1 | 5 | 4 | 2 |
| Beginning Cash Position | 7,851 | 7,851 | 3,680 | 3,635 | 3,680 |
| End Cash Position | 12,650 | 3,693 | 7,851 | 9,245 | 11,808 |
| Net Cash Flow | $4,799 | $-4,158 | $4,171 | $5,609 | $8,128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,060 | -4,115 | -6,469 | -5,015 | -2,497 |
| Capital Expenditure | N/A | N/A | -37 | N/A | N/A |
| Free Cash Flow | -6,060 | -4,115 | -6,506 | -5,015 | -2,497 |